Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
Go back to Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care| Edwards Lifesciences (NYSE: EW) | Delayed: 91.78 +0.96 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.82 | 52 Week High | $166.87 | |||
| Open | $89.98 | 52 Week Low | $72.20 | |||
| Day High | $92.12 | P/E | 26.68 | |||
| Day Low | $89.90 | EPS | $3.44 | |||
| Volume | 2,296,562 | |||||



